Eric Tridas

Title: Innovations by Eric Tridas in Onychomycosis Treatment

Introduction

Eric Tridas is an accomplished inventor based in St. Petersburg, FL (US). He has made significant contributions to the field of medical treatments, particularly focusing on innovative solutions for onychomycosis, a common nail fungal infection. With a total of two patents to his name, Tridas is recognized for his unique approach to addressing this health issue.

Latest Patents

Tridas's latest patents include a groundbreaking system and method for treating onychomycosis. This innovative treatment involves the delivery of a redox gas solution, which comprises a reactive species dissolved in a perfluorocarbon liquid. The perfluorocarbon liquid is dispensed onto a gas-permeable membrane and includes an anti-inflammatory component. The reactive species utilized in this treatment may consist of reactive oxygen, reactive nitrogen, reactive chlorine, or reactive bromine species. Notably, the perfluorocarbon liquid may include perfluorodecalin, enhancing the effectiveness of the treatment.

Career Highlights

Throughout his career, Eric Tridas has worked with various companies, including Devicefarm, Inc. His experience in the industry has allowed him to develop and refine his innovative ideas, leading to the successful patenting of his treatment methods.

Collaborations

Tridas has collaborated with notable professionals in his field, including Jeffrey N. Roe and Timothy C. Grammer. These collaborations have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Eric Tridas stands out as a notable inventor in the medical field, particularly for his innovative solutions to treat onychomycosis. His patents reflect a commitment to improving health outcomes through advanced technology and collaboration.